Eurofins Scientifi (NASDAQ:ERFSF) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Tuesday.

According to Zacks, “Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. “

Eurofins Scientifi (NASDAQ:ERFSF) traded down 3.2067% during midday trading on Tuesday, hitting $628.4011. 16 shares of the stock traded hands. The company’s 50 day moving average is $622.21 and its 200-day moving average is $562.66. Eurofins Scientifi has a one year low of $413.57 and a one year high of $638.00. The company has a market cap of $10.69 billion and a P/E ratio of 62.9030.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/31/eurofins-scientifi-erfsf-downgraded-by-zacks-investment-research-to-hold.html.

Get a free copy of the Zacks research report on Eurofins Scientifi (ERFSF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Eurofins Scientifi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scientifi and related companies with MarketBeat.com's FREE daily email newsletter.